Athero Review - Issue 1/2025
Guidelines
8
SAA Consensus Statement EAS 2021: Triglyceride-rich lipoproteins and their remnant particles – a review of metabolism, role in atherosclerotic cardiovascular disease, and new therapeutic strategies
Branislav Vohnout, Martin Čaprnda, Ubomíra Fábryová, Anna Hlavatá, Michaela Kadurová, Ján Lietava, Daniel Pella, Katarína Rašlová, Jana Sirotiaková, Jana Tisoňová, Štefan Tóth
19
The use of fenofibrate in the prevention of diabetic retinopathy progression: an interdisciplinary consensus
Martin Prázný, Tomáš Sosna, Libor Hejsek, Jarmila Heissigerová, Michal Vrablík Za Panel Odborníků, Zuzana Zafarová
Reviews
23
Determination and current management options for statin intolerance
Lukáš Olšavský, Štefan Tóth, Adriána Jarolímková
30
33
38
Targeting lipoprotein(a): modification of cardiovascular risk and current treatment options
Tibor Porubän, Štefan Tóth
45
Possibilities of using telemedicine methods in the management of lipitension
Adriána Jarolímková, Patrik Buček, Štefan Tóth
53
Telemedicine in the management of lipitension – opportunities and barriers to its use in Slovakia from the patient's perspective: a questionnaire study
Štefan Tóth, Adriána Jarolímková, Patrik Buček
62
Dutch Lipid Clinic Network Score – an effective tool for the diagnosis of familial hypercholesterolemia
Katarína Rašlová, Miloslava Hučková, Soňa Wimmerová, Ján Chandoga, Miriama Juhosová
From International Literature
Annoucements
69
Athero Review
2025 Issue 1
Most read in this issue
- SAA Consensus Statement EAS 2021: Triglyceride-rich lipoproteins and their remnant particles – a review of metabolism, role in atherosclerotic cardiovascular disease, and new therapeutic strategies
- Determination and current management options for statin intolerance
- Targeting lipoprotein(a): modification of cardiovascular risk and current treatment options
- The use of fenofibrate in the prevention of diabetic retinopathy progression: an interdisciplinary consensus